Sanderson RD - Search Results

1

Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.

Kelly T, Suva LJ, Huang Y, Macleod V, Miao HQ, Walker RC, Sanderson RD. Kelly T, et al. Among authors: sanderson rd. Cancer Res. 2005 Jul 1;65(13):5778-84. doi: 10.1158/0008-5472.CAN-05-0749. Cancer Res. 2005. PMID: 15994953

2

Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma.

Dhodapkar MV, Kelly T, Theus A, Athota AB, Barlogie B, Sanderson RD. Dhodapkar MV, et al. Among authors: sanderson rd. Br J Haematol. 1997 Nov;99(2):368-71. doi: 10.1046/j.1365-2141.1997.3893203.x. Br J Haematol. 1997. PMID: 9375756 Free article.

3

Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9.

Kaushal GP, Xiong X, Athota AB, Rozypal TL, Sanderson RD, Kelly T. Kaushal GP, et al. Among authors: sanderson rd. Br J Haematol. 1999 Feb;104(2):365-73. doi: 10.1046/j.1365-2141.1999.01180.x. Br J Haematol. 1999. PMID: 10050721 Free article.

4

Matrix metalloproteinases in multiple myeloma.

Kelly T, Børset M, Abe E, Gaddy-Kurten D, Sanderson RD. Kelly T, et al. Among authors: sanderson rd. Leuk Lymphoma. 2000 Apr;37(3-4):273-81. doi: 10.3109/10428190009089428. Leuk Lymphoma. 2000. PMID: 10752979 Review.

5

Soluble syndecan-1 promotes growth of myeloma tumors in vivo.

Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, Epstein J, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. Blood. 2002 Jul 15;100(2):610-7. doi: 10.1182/blood.v100.2.610. Blood. 2002. PMID: 12091355 Free article.

6

Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis.

Pumphrey CY, Theus AM, Li S, Parrish RS, Sanderson RD. Pumphrey CY, et al. Among authors: sanderson rd. Cancer Res. 2002 Jul 1;62(13):3722-8. Cancer Res. 2002. PMID: 12097281

7

High heparanase activity in multiple myeloma is associated with elevated microvessel density.

Kelly T, Miao HQ, Yang Y, Navarro E, Kussie P, Huang Y, MacLeod V, Casciano J, Joseph L, Zhan F, Zangari M, Barlogie B, Shaughnessy J, Sanderson RD. Kelly T, et al. Among authors: sanderson rd. Cancer Res. 2003 Dec 15;63(24):8749-56. Cancer Res. 2003. PMID: 14695190

8

Heparanase promotes the spontaneous metastasis of myeloma cells to bone.

Yang Y, Macleod V, Bendre M, Huang Y, Theus AM, Miao HQ, Kussie P, Yaccoby S, Epstein J, Suva LJ, Kelly T, Sanderson RD. Yang Y, et al. Among authors: sanderson rd. Blood. 2005 Feb 1;105(3):1303-9. doi: 10.1182/blood-2004-06-2141. Epub 2004 Oct 7. Blood. 2005. PMID: 15471949 Free article.

9

Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis.

Sanderson RD, Yang Y, Suva LJ, Kelly T. Sanderson RD, et al. Matrix Biol. 2004 Oct;23(6):341-52. doi: 10.1016/j.matbio.2004.08.004. Matrix Biol. 2004. PMID: 15533755 Review.

10

Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.

Sanderson RD, Yang Y, Kelly T, MacLeod V, Dai Y, Theus A. Sanderson RD, et al. J Cell Biochem. 2005 Dec 1;96(5):897-905. doi: 10.1002/jcb.20602. J Cell Biochem. 2005. PMID: 16149080 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page